J. Andrew Livingston, MD, MS

Associate Professor
The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Houston, Texas, United States

Disclosure information not submitted.

Presentation(s):

• Paper 21 - PHASE 1 RESULTS OF THE WEE1 INHIBITOR, AZENOSERTIB, IN COMBINATION WITH GEMCITABINE IN ADULT AND PEDIATRIC PATIENTS WITH RELAPSED OR REFRACTORY OSTEOSARCOMA

  Thursday, November 14, 2024
  1:45 PM – 3:15 PM PST

• Paper 23 - A PHASE 1/2 TRIAL OF GEMCITABINE, DOCETAXEL, AND HYDROXYCHLOROQUINE IN ADVANCED METASTATIC OSTEOSARCOMA: FINAL RESULTS

  Thursday, November 14, 2024
  1:45 PM – 3:15 PM PST

• Paper 53 - ADDRESSING THE PRIMARY SITE IN PATIENTS WITH METASTATIC SOFT TISSUE SARCOMA: IS THERE A ROLE FOR A COMBINED MODALITY TREATMENT?

  Friday, November 15, 2024
  11:15 AM – 12:45 PM PST

• Paper 99 - INCIDENCE OF GERMLINE GENETIC MUTATIONS IDENTIFIED ON STANDARD-OF-CARE GENOMIC SEQUENCING FOR ADVANCED SARCOMAS

  Saturday, November 16, 2024
  2:00 PM – 3:00 PM PST